Major Ingredients

Diclofenac sodium BP 1.00mg/ml.

Major Functionality

Postoperative inflammation after cataract surgery and other surgical procedures. Preoperative and postoperative prevention of cystoid macular oedema associated with lens extraction and intraocular lens implantation. Non-infectious inflammatory conditions affecting the anterior region of the eye (e.g. chronic non-infectious conjunctivitis). Posttraumatic inflammation in penetrating wounds (as an adjuvant to local antiinfective therapy).

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.